mitotane has been researched along with Corpus Luteum Cyst in 2 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitotane is an adrenolytic drug that is used as an adjuvant to treat adrenocortical carcinoma." | 7.96 | Ovarian cyst formation in women of reproductive age receiving mitotane as part of the treatment of adrenocortical carcinoma: Clinical and experimental observations. ( Abrahamsson, G; Ahlman, H; Ekerhovd, E; Janson, PO; Jansson, S; Norström, A; Wängberg, B, 2020) |
| "Mitotane is an adrenolytic and anticortisolic drug used in adrenocortical carcinoma (ACC), Cushing's disease (CD), and ectopic ACTH syndrome." | 7.81 | Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease. ( Bachelot, A; Baudin, E; Bernard, V; Bry-Gauillard, H; Chanson, P; Crinière, L; Do Cao, C; Droumaguet, C; Guignat, L; Leboulleux, S; Maiter, D; Pierre, P; Salenave, S; Santulli, P; Schlumberger, M; Touraine, P; Young, J, 2015) |
| "Mitotane is an adrenolytic drug that is used as an adjuvant to treat adrenocortical carcinoma." | 3.96 | Ovarian cyst formation in women of reproductive age receiving mitotane as part of the treatment of adrenocortical carcinoma: Clinical and experimental observations. ( Abrahamsson, G; Ahlman, H; Ekerhovd, E; Janson, PO; Jansson, S; Norström, A; Wängberg, B, 2020) |
| "Mitotane is an adrenolytic and anticortisolic drug used in adrenocortical carcinoma (ACC), Cushing's disease (CD), and ectopic ACTH syndrome." | 3.81 | Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease. ( Bachelot, A; Baudin, E; Bernard, V; Bry-Gauillard, H; Chanson, P; Crinière, L; Do Cao, C; Droumaguet, C; Guignat, L; Leboulleux, S; Maiter, D; Pierre, P; Salenave, S; Santulli, P; Schlumberger, M; Touraine, P; Young, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsson, G | 1 |
| Ekerhovd, E | 1 |
| Janson, PO | 1 |
| Jansson, S | 1 |
| Ahlman, H | 1 |
| Wängberg, B | 1 |
| Norström, A | 1 |
| Salenave, S | 1 |
| Bernard, V | 1 |
| Do Cao, C | 1 |
| Guignat, L | 1 |
| Bachelot, A | 1 |
| Leboulleux, S | 1 |
| Droumaguet, C | 1 |
| Bry-Gauillard, H | 1 |
| Pierre, P | 1 |
| Crinière, L | 1 |
| Santulli, P | 1 |
| Touraine, P | 1 |
| Chanson, P | 1 |
| Schlumberger, M | 1 |
| Maiter, D | 1 |
| Baudin, E | 1 |
| Young, J | 1 |
2 other studies available for mitotane and Corpus Luteum Cyst
| Article | Year |
|---|---|
Ovarian cyst formation in women of reproductive age receiving mitotane as part of the treatment of adrenocortical carcinoma: Clinical and experimental observations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Amenorrhea; Antineoplastic Agents, Hormon | 2020 |
Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease.
Topics: Adolescent; Adrenocortical Carcinoma; Adult; Antineoplastic Agents, Hormonal; Biomarkers; Female; Go | 2015 |